Company Overview

Company name: Dosist
Description: Developer of proprietary vaporizing dose-pens created to provide safe, targeted and effective cannabis-based therapies. The company’s dose-pens are developed to activate the balance of cannabis compounds that deliver functional benefits to the human body through interaction with the endocannabinoid system, enabling users to replace pills for common ailments that do as much harm as good.
Year founded: 2016
Parent company:
Industry: Healthcare | Group: Healthcare Devices and Supplies | Code:
Website: www.dosist.com
Employees:
City: Stamford
State: Connecticut
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company raised venture funding from Sinai Ventures on an undisclosed date.
Number of active investors:
Profile last updated: 30-Oct-2018
Last known valuation:
Last known valuation date: